These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22426996)

  • 1. Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.
    Weninger S; De Maeyer JH; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):565-77. PubMed ID: 22426996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium.
    Weninger S; De Maeyer JH; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):671-84. PubMed ID: 23549671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.
    De Maeyer JH; Straetemans R; Schuurkes JA; Lefebvre RA
    Br J Pharmacol; 2006 Jan; 147(2):140-57. PubMed ID: 16331294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
    Galindo-Tovar A; Vargas ML; Escudero E; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(2):237-49. PubMed ID: 19154438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
    Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium.
    Kaumann AJ; Levy FO
    Br J Pharmacol; 2006 Jan; 147(2):128-30. PubMed ID: 16331292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which phosphodiesterase can decrease cardiac effects of 5-HT
    Neumann J; Käufler B; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):991-1004. PubMed ID: 31016326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of phosphodiesterases on basal and 5-HT₄ receptor facilitated cholinergic contractility in pig descending colon.
    Priem EK; De Maeyer JH; Lefebvre RA
    Eur J Pharmacol; 2013 Apr; 705(1-3):156-63. PubMed ID: 23454061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.
    Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):665-70. PubMed ID: 23649864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The facilitating effect of prucalopride on cholinergic neurotransmission in pig gastric circular muscle is regulated by phosphodiesterase 4.
    Priem E; Van Colen I; De Maeyer JH; Lefebvre RA
    Neuropharmacology; 2012 Apr; 62(5-6):2126-35. PubMed ID: 22266217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.
    Krobert KA; Brattelid T; Levy FO; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
    Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between 5-HT
    Pauwelyn V; Ceelen W; Lefebvre RA
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28799255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
    Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
    Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of the human 5-HT
    Gergs U; Fritsche J; Fabian S; Christ J; Neumann J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):987-996. PubMed ID: 28689254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.